Skip to main content
رجوع
Watch Compare

Silexion Therapeutics Corp

جودة البيانات: 83%
مُدرج أيضًا باسم SLXNW NASDAQ
SLXN
NASDAQ Manufacturing Chemicals
KWD 1.05
▲ KWD 0.05 (4.50%)
6 months return
—
Momentum
Neutral
ROE
-335.69%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-335.69%
أقل من متوسط القطاع (-54.68%)
ROIC-147.32%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio3.97
Interest CoverageN/A

التقييم

P/E Ratio
-0.31 TTM
أعلى من متوسط القطاع (-1.49)
P/B Ratio0.53
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -10.83 M

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

2 محللين
Strong Buy
+474.2%
upside to target
الحالي
KWD 1.05
Consensus Target
KWD 6.00
KWD 6.00
أدنى
KWD 6.00
أعلى
التوقعات
ربحية السهم المستقبلية
-KWD 2.87
الإيرادات المقدّرة
0.0

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 1.29 · Rev Est: 0.0
Q32025 Q42025 Q1 '26 Q2 '26
Reported -KWD 2.88 — — —
Estimate -KWD 3.40 -KWD 1.12 -KWD 1.29 -KWD 1.31
المفاجأة +15.29% — — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -335.69% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -11.91 M
ROE -335.69% ROA -136.83%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -10.83 M
ROIC -147.32% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 3.97
Debt / Equity N/A Current Ratio 3.97
Interest Coverage N/A Asset Turnover N/A
Working Capital 8.27 M Tangible Book Value 6.98 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.31 · EV/EBITDA: N/A
P/E Ratio -0.31 Forward P/E N/A
P/B Ratio 0.53 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -292.87%
Market Cap 3.70 M Enterprise Value -5.55 M

Per Share

EPS: 8.96 · FCF/Share: -3.25
EPS (Diluted TTM) 8.96 Revenue / Share N/A
FCF / Share -3.25 OCF / Share -3.25
EPS CAGR (1Y) -66.01% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 90.90% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 90.90%
SBC-Adj. FCF -10.99 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income -11.91 M -16.52 M
EPS (Diluted) 8.96 26.36
Gross Profit — —
Operating Income -11.63 M -12.57 M
EBITDA — —
R&D Expenses 7.14 M 5.82 M
SG&A Expenses — —
D&A — —
Interest Expense — —
Income Tax 3,000.0 10,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 7.22 M 2.86 M
Total Liabilities 4.61 M 6.85 M
Shareholders' Equity 2.60 M -3.99 M
Total Debt — —
Cash & Equivalents 5.99 M 1.19 M
Current Assets 6.64 M 2.25 M
Current Liabilities 2.76 M 3.52 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -0.3 -1.5
P/B 0.5 1.6
ROE % -335.7 -54.7
Net Margin % — -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3